| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9726 | 
      | Human Intestinal Absorption | HIA+ | 0.9873 | 
      | Caco-2 Permeability | Caco2+ | 0.5851 | 
      | P-glycoprotein Substrate | Non-substrate | 0.7339 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.7870 | 
                                                     | Non-inhibitor | 0.9193 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9216 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.8543 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8747 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.9162 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.7108 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.8533 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9329 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9516 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.8897 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.9785 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9132 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9711 | 
                                                                    | Non-inhibitor | 0.9755 | 
      | AMES Toxicity | Non AMES toxic | 0.9369 | 
      | Carcinogens | Carcinogens  | 0.6352 | 
      | Fish Toxicity | High FHMT | 0.6128 | 
      | Tetrahymena Pyriformis Toxicity | Low TPT | 0.8804 | 
      | Honey Bee Toxicity | High HBT | 0.8213 | 
      | Biodegradation | Ready biodegradable | 0.8885 | 
      | Acute Oral Toxicity | III | 0.8004 | 
      | Carcinogenicity (Three-class) | Non-required | 0.7128 |